No article text was recorded for this version.
non-specific immunosuppression
Version 2 of 240 papers48 conceptsfrozen 2026-10-04
Papers in this version
- Blog: Conditional depletion of macrophages ameliorates cholestatic liver injury and fibrosis via lncRNA-H19
- Blog: Negative Regulator Nlrc3-like Maintain the Balanced Innate Immune Response During Mycobacterial Infection in Zebrafish
- Blog: Inhibition of FLT3 signaling targets DCs to ameliorate autoimmune disease
- Blog: Twist1 and Hopx determine function and persistence of pathogenic memory/effector T cells
- Blog: Immunological Crossroads: Optimizing Antirejection Regimens to Sustain Antitumor Immunity in Liver Transplant Recipients with Hepatocellular Carcinoma
- Blog: E3 ligase FBXW7 is critical for RIG-I stabilization during antiviral responses
- Blog: Precision targeting of autoantigen-specific B cells in muscle-specific tyrosine kinase myasthenia gravis with chimeric autoantibody receptor T cells
- Blog: Anti-human TLR7 antibody for therapeutic intervention in systemic lupus erythematosus
- Blog: Cancer Inflammation
- Blog: TNF-α induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand
- Blog: The allosteric modulation of Complement C5 by knob domain peptides
- Blog: Research progress on neutrophil extracellular traps and hepatitis‑to‑hepatocellular carcinoma transformation (Review)
- Blog: Uncovering lupus nephritis-specific genes and the potential of TNFRSF17-targeted immunotherapy: a high-throughput sequencing study
- Blog: Single-cell multi-omics analysis revealed the expansion of age-associated B cells in the pancreas of type 1 autoimmune pancreatitis patients
- Blog: Phosphatidylserine-microbubble targeting-activated microglia/macrophage in inflammation combined with ultrasound for breaking through the blood–brain barrier
- Blog: The Long Noncoding RNA IFNG-AS1 Promotes T Helper Type 1 Cells Response in Patients with Hashimoto’s Thyroiditis
- Blog: A targetable ‘rogue’ neutrophil-subset, [CD11b+DEspR+] immunotype, is associated with severity and mortality in acute respiratory distress syndrome (ARDS) and COVID-19-ARDS
- Blog: A Requirement of Protein Geranylgeranylation for Chemokine Receptor Signaling and Th17 Cell Function in an Animal Model of Multiple Sclerosis
- Blog: Disease-driving CD4+ T cell clonotypes persist for decades in celiac disease
- Blog: Fibroblastic niches prime T cell alloimmunity through Delta-like Notch ligands
- Blog: LPX-TI641, a Tim3/4 Agonist, Induces Long-Term Immune Tolerance in Multiple Sclerosis Models
- Blog: Nutritional control of IL-23/Th17-mediated autoimmune disease through HO-1/STAT3 activation
- Blog: Application and prospect of targeting innate immune sensors in the treatment of autoimmune diseases
- Blog: Anti-Inflammatory Effects of Recombinant Human PDCD5 (rhPDCD5) in a Rat Collagen-Induced Model of Arthritis
- Blog: Targeting early changes in the synovial microenvironment: a new class of immunomodulatory therapy?
- Blog: Monocyte-endothelial cell interactions in vascular and tissue remodeling
- Blog: Carnosol inhibits inflammasome activation by directly targeting HSP90 to treat inflammasome-mediated diseases
- Blog: WDR77 inhibits prion-like aggregation of MAVS to limit antiviral innate immune response
- Blog: Virus-induced senescence is a driver and therapeutic target in COVID-19
- Blog: A Case of Aplastic Anemia Associated with Systemic Lupus Erythematosus: Successful Treatement with Cyclosporine
- Blog: SARS-CoV-2 N protein induced acute kidney injury in diabetic db/db mice is associated with a Mincle-dependent M1 macrophage activation
- Blog: Efficacy of Synthetic Peptide Corresponding to the ACTH-Like Sequence of Human Immunoglobulin G1 in Experimental Autoimmune Encephalomyelitis
- Blog: Spermidine alleviates experimental autoimmune encephalomyelitis through inducing inhibitory macrophages
- Blog: Duvelisib is a novel NFAT inhibitor that mitigates adalimumab-induced immunogenicity
- Blog: Cepharanthine Blocks Presentation of Thyroid and Islet Peptides in a Novel Humanized Autoimmune Diabetes and Thyroiditis Mouse Model
- Blog: Embryonic Stem Cells Promoting Macrophage Survival and Function are Crucial for Teratoma Development
- Blog: The early marginal zone B cell initiated T independent type 2 response resists the proteasome inhibitor bortezomib
- Blog: Disulfiram alleviates pristane-induced lupus via inhibiting GSDMD-mediated pyroptosis
- Blog: Development of cyclopeptide inhibitors of cGAS targeting protein-DNA interaction and phase separation
- Blog: Unveiling the hidden role of the interaction between CD36 and FcγRIIb: implications for autoimmune disorders
History & citation
Current · Permanent link
Cite this direction
Latest version (a living page):
@misc{lacuna_non_specific_immunosuppression_4c0f830a,
title = {non-specific immunosuppression},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/non-specific-immunosuppression/rdr_4c0f830a840e43919979faa366b68114},
note = {Latest version of a living research direction; cite a version for a fixed text. Accessed 2026-11-19},
}This exact version (version 2, frozen text):
@misc{lacuna_non_specific_immunosuppression_4c0f830a_v2,
title = {non-specific immunosuppression},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/non-specific-immunosuppression/rdr_4c0f830a840e43919979faa366b68114/v/2},
note = {Version 2, frozen 2026-10-04. Accessed 2026-11-19},
}